Calcium Channel Blockers - Pharmacology

1. A 51-year-old patient suffers a subarachnoid hemorrhage. To prevent delayed cerebral ischemia from vasospasm, a specific calcium channel blocker is administered. Which drug is used for this indication and what is the primary reason for its selection?
   Answer: Nimodipine, due to its high lipid solubility and relative selectivity for cerebral arteries. Nimodipine, a dihydropyridine calcium channel blocker, is specifically approved for preventing cerebral vasospasm following subarachnoid hemorrhage. Its high lipophilicity allows it to effectively cross the blood-brain barrier, and it demonstrates a somewhat greater effect on cerebral arteries compared to other peripheral arteries. The other agents are not the standard of care for this specific indication.
2. When comparing verapamil and diltiazem, which statement is most accurate regarding their relative clinical effects?
   Answer: Verapamil exhibits greater suppressive effects on cardiac contractility and conduction than diltiazem. Both are non-dihydropyridines, but they are not identical. Verapamil is considered more cardio-depressant than diltiazem, with stronger negative inotropic (contractility) and chronotropic/dromotropic (conduction) effects. Diltiazem has a more intermediate profile with balanced cardiac and vascular effects. Verapamil is also more likely to cause constipation. Neither causes reflex tachycardia.
3. A 72-year-old female with hypertension and NYHA Class III systolic heart failure (ejection fraction 30%) requires an additional agent for blood pressure control. Her current regimen includes lisinopril, carvedilol, and furosemide. Initiation of which of the following calcium channel blockers carries the highest risk of clinical decompensation?
   Answer: Verapamil Verapamil is a non-dihydropyridine calcium channel blocker with significant negative inotropic (decreased contractility) and chronotropic (decreased heart rate) effects. In a patient with pre-existing systolic heart failure, these effects can worsen cardiac output and lead to clinical decompensation. Dihydropyridines like amlodipine and felodipine have minimal effects on cardiac contractility and are generally considered safer if a calcium channel blocker is needed in this population.
4. A patient with stable angina and hypertension is well-managed on metoprolol succinate. However, her blood pressure remains elevated at 150/92 mmHg. The addition of which of the following medications carries the highest risk of inducing symptomatic bradycardia or atrioventricular block?
   Answer: Diltiazem Combining a beta-blocker (metoprolol) with a non-dihydropyridine calcium channel blocker (diltiazem or verapamil) can lead to an additive suppression of both the sinoatrial (SA) and atrioventricular (AV) nodes. This significantly increases the risk of severe bradycardia, heart block, and decreased cardiac contractility. Dihydropyridines (nifedipine, amlodipine) have minimal effects on the SA/AV nodes and are a safer combination with beta-blockers. Chlorthalidone is a diuretic and does not have this interaction.
5. A 68-year-old male with a history of persistent atrial fibrillation and hypertension presents for follow-up. His ventricular rate is consistently 110-120 bpm and his blood pressure is 155/95 mmHg. He is not currently on any rate-controlling or antihypertensive agents. Which of the following is the most appropriate single agent to address both conditions?
   Answer: Diltiazem Diltiazem is a non-dihydropyridine calcium channel blocker that has effects on both vascular smooth muscle (lowering blood pressure) and the atrioventricular (AV) node (slowing conduction and controlling ventricular rate in atrial fibrillation). Amlodipine and nifedipine are dihydropyridines that primarily act on vascular smooth muscle and can cause reflex tachycardia, making them unsuitable for rate control. Lisinopril is an ACE inhibitor that lowers blood pressure but has no direct effect on heart rate control.
6. A 55-year-old male is initiated on immediate-release nifedipine for severe hypertension. His blood pressure improves, but he reports palpitations. An ECG confirms sinus tachycardia with a heart rate of 115 bpm. Which of the following best explains the physiological mechanism for this patient's tachycardia?
   Answer: Baroreceptor-mediated increase in sympathetic outflow due to peripheral vasodilation. Dihydropyridine calcium channel blockers like nifedipine are potent peripheral vasodilators. The resulting rapid drop in blood pressure is sensed by baroreceptors, triggering a compensatory reflex increase in sympathetic nervous system outflow. This leads to increased heart rate (tachycardia) and contractility. The other options describe incorrect mechanisms.
7. When comparing the effects of nifedipine and diltiazem in treating chronic stable angina, which statement accurately describes their differential impact on the major determinants of myocardial oxygen demand (MVO2)?
   Answer: Diltiazem reduces MVO2 by decreasing afterload, heart rate, and contractility; nifedipine's reduction in afterload may be offset by reflex tachycardia. Myocardial oxygen demand is determined by heart rate, contractility, and wall tension (related to afterload and preload). Diltiazem (a non-DHP) reduces all three: it decreases heart rate and contractility directly, and reduces afterload. Nifedipine (a DHP) potently reduces afterload, but the resulting reflex tachycardia can increase heart rate and contractility, partially or completely offsetting the benefit of afterload reduction on MVO2.
8. Which statement best contrasts the primary site of action of verapamil versus that of nifedipine?
   Answer: Verapamil has relatively equipotent effects on myocardial and vascular smooth muscle calcium channels. The key difference lies in tissue selectivity. Verapamil (a non-dihydropyridine) acts on L-type calcium channels in both cardiac tissue (SA node, AV node, myocardium) and vascular smooth muscle. In contrast, nifedipine (a dihydropyridine) is significantly more selective for L-type calcium channels in vascular smooth muscle, with minimal direct effects on the heart at therapeutic concentrations. Both primarily affect L-type channels and are more active on arterioles than veins.
9. A 65-year-old woman being treated with a high-intensity statin for hyperlipidemia is diagnosed with hypertension. Her physician initiates a new medication. One month later, she presents with severe myalgia and weakness. Laboratory tests show a markedly elevated creatine kinase level, suggesting rhabdomyolysis. The new medication is most likely which of the following?
   Answer: Verapamil Verapamil (and diltiazem) are potent inhibitors of the cytochrome P450 3A4 (CYP3A4) enzyme. Many statins, including simvastatin and atorvastatin, are metabolized by CYP3A4. Co-administration of verapamil can significantly increase statin levels, raising the risk of myopathy and rhabdomyolysis. Dihydropyridines like amlodipine and nifedipine are much weaker CYP3A4 inhibitors and are less likely to cause this interaction. Hydrochlorothiazide is not a significant CYP3A4 inhibitor.
10. A patient taking amlodipine for hypertension develops prominent peripheral edema. The addition of which class of antihypertensive medication is most likely to mitigate this specific side effect?
    Answer: An angiotensin-converting enzyme (ACE) inhibitor, such as lisinopril. Dihydropyridine-induced edema results from preferential arteriolar dilation, which increases intracapillary pressure. ACE inhibitors and angiotensin II receptor blockers (ARBs) cause balanced vasodilation of both arterioles and venules. The venodilation helps to reduce the intracapillary pressure, thereby counteracting the fluid shift caused by the amlodipine. Diuretics may reduce total fluid volume but do not address the underlying hemodynamic imbalance. Beta-blockers and other CCBs would not correct this specific mechanism.
11. A 62-year-old patient on amlodipine for hypertension develops significant, pitting, bilateral lower extremity edema. This side effect is primarily caused by which of the following hemodynamic mechanisms?
    Answer: Increased capillary hydrostatic pressure from preferential precapillary arteriolar vasodilation. Dihydropyridine calcium channel blockers like amlodipine cause potent vasodilation of precapillary arterioles but have minimal effect on postcapillary venules. This imbalance increases the hydrostatic pressure within the capillary bed, leading to extravasation of fluid into the interstitial space and causing peripheral edema. The other options describe incorrect mechanisms for this specific side effect.
12. A 45-year-old patient on long-term therapy with a calcium channel blocker for hypertension presents to their dentist with significant swelling and bleeding of the gums. The dentist diagnoses drug-induced gingival hyperplasia. This adverse effect is most characteristic of which of the following agents?
    Answer: Nifedipine Gingival hyperplasia is a known class effect of calcium channel blockers, particularly the dihydropyridines, with nifedipine being the most frequently implicated agent. The mechanism is not fully understood but is thought to involve effects on fibroblast function. Metoprolol (beta-blocker), lisinopril (ACE inhibitor), and furosemide (loop diuretic) are not typically associated with this adverse effect.
13. The antihypertensive effect of dihydropyridine calcium channel blockers is primarily mediated by their action on which target?
    Answer: L-type calcium channels in arteriolar smooth muscle, reducing systemic vascular resistance. Dihydropyridine calcium channel blockers exhibit high selectivity for L-type calcium channels in the smooth muscle of peripheral arterioles. Blockade of these channels prevents calcium influx, leading to smooth muscle relaxation, vasodilation, and a subsequent decrease in systemic vascular resistance (afterload), which lowers blood pressure. Their effects on veins, the SA node (which would be bradycardia), and renin release are minimal compared to their potent arteriolar effect.
14. A patient with hypertension requires therapy with a calcium channel blocker. They have a history of second-degree atrioventricular block (Mobitz I). Which of the following agents would be the most appropriate choice?
    Answer: Amlodipine Non-dihydropyridine calcium channel blockers (verapamil and diltiazem) suppress atrioventricular (AV) nodal conduction and are contraindicated in patients with pre-existing second- or third-degree AV block. Dihydropyridine calcium channel blockers, such as amlodipine, have minimal effect on AV conduction and are therefore a much safer choice for controlling hypertension in this patient.
15. A 58-year-old male with hypertension is prescribed a calcium channel blocker. He returns a month later complaining of significant constipation, which is a new symptom for him. Which of the following drugs was most likely prescribed?
    Answer: Verapamil Constipation is a well-known and common side effect of verapamil due to its effect on blocking L-type calcium channels in the smooth muscle of the gastrointestinal tract, leading to decreased motility. While diltiazem can also cause constipation, it is most pronounced with verapamil. Dihydropyridines (nifedipine, amlodipine, felodipine) are much less likely to cause this particular side effect.
16. A patient with Prinzmetal (vasospastic) angina experiences episodes of chest pain at rest. The pathophysiology involves coronary artery spasm. Which of the following provides the most targeted mechanism for preventing these episodes?
    Answer: Amlodipine, by potently relaxing coronary arterial smooth muscle. The primary goal in treating vasospastic angina is to prevent and relieve coronary artery spasm. Dihydropyridine calcium channel blockers like amlodipine and nifedipine are potent vasodilators of arterial smooth muscle, including the coronary arteries. This makes them highly effective for this condition. While non-dihydropyridines also cause coronary vasodilation, their primary benefits in other types of angina relate to decreasing myocardial oxygen demand (by reducing heart rate and contractility), which is not the principal mechanism needed for vasospastic angina.
17. Which property best explains why diltiazem is effective for ventricular rate control in atrial fibrillation, whereas amlodipine is not?
    Answer: Diltiazem slows calcium-dependent action potentials in the atrioventricular node. Non-dihydropyridines like diltiazem exert their rate-controlling effect by blocking L-type calcium channels in the atrioventricular (AV) node. Since AV nodal conduction is dependent on the slow inward calcium current, this action decreases the speed of conduction and increases the refractory period, thus slowing the ventricular response to atrial fibrillation. Dihydropyridines like amlodipine have minimal electrophysiological effects on the AV node at therapeutic doses.
18. The cardiac action potential in atrioventricular (AV) nodal cells is characterized by a slow upstroke (Phase 0) that is dependent on calcium influx. A non-dihydropyridine calcium channel blocker would exert its primary dromotropic effect by directly altering which phase?
    Answer: Slowing the rate of depolarization during Phase 0. The action potential of SA and AV nodal cells is dependent on the inward calcium current (I_Ca) for its depolarization phase (Phase 0). Non-dihydropyridine CCBs block these L-type calcium channels, reducing the slope and amplitude of Phase 0. This directly slows the conduction velocity (negative dromotropic effect) through the AV node. In contrast, ventricular myocyte Phase 0 is sodium-dependent.
19. A patient with severe aortic stenosis is noted to have a fixed cardiac output. Which of the following medications would be most dangerous to administer for co-existing hypertension in this patient?
    Answer: Verapamil In severe aortic stenosis, cardiac output is relatively fixed and dependent on adequate preload and heart rate. Survival depends on maintaining systemic vascular resistance (SVR). Potent vasodilators can cause a precipitous drop in blood pressure and coronary perfusion. While dihydropyridines (Amlodipine, Felodipine) also cause vasodilation, verapamil is particularly dangerous because it not only reduces SVR but also has potent negative inotropic and chronotropic effects, which could critically compromise the already-impaired cardiac output.

Start this quiz